Literature DB >> 17409428

Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis.

Rachel W Kasinskas1, Neil S Forbes.   

Abstract

The effectiveness of most chemotherapeutics is limited by their inability to penetrate deep into tumor tissue and their ineffectiveness against quiescent cells. Motile Salmonella typhimurium, which are specifically attracted to compounds produced by quiescent cancer cells, could overcome this therapeutic barrier. We hypothesized that individual chemoreceptors target S. typhimurium to specific tumor microenvironments. To test this hypothesis, we used time-lapse fluorescent microscopy and tumor cylindroids to quantify the accumulation of chemotaxis machinery knockouts, including strains lacking individual cell surface chemoreceptors, chemotaxis signal transduction pathway enzymes, and the flagella and motor assemblies. To measure the extent of apoptosis induced by individual bacterial strains, caspase-3 activity was measured as a function of time. Our results showed how chemoreceptors directed bacterial chemotaxis within cylindroids: the aspartate receptor initiated chemotaxis toward cylindroids, the serine receptor initiated penetration, and the ribose/galactose receptor directed S. typhimurium toward necrosis. In addition, strains lacking proper flagella constructs, signal transduction proteins, or active motor function did not chemotax toward tumor cylindroids, indicating that directed chemotaxis is necessary to promote accumulation in tumors. By deleting the ribose/galactose receptor, bacterial accumulation localized to tumor quiescence and had a greater individual effect on inducing apoptosis than wild-type S. typhimurium. This new understanding of the mechanisms of Salmonella migration in tumors will allow for the development of bacterial therapies with improved targeting to therapeutically inaccessible regions of tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409428     DOI: 10.1158/0008-5472.CAN-06-2618

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  68 in total

1.  A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Authors:  Kelly Flentie; Brandon Kocher; Seth T Gammon; Deborah V Novack; Jeffrey S McKinney; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

2.  Mimicking in vivo tumors to visualize the cell cycle.

Authors:  Jung-Joon Min
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

4.  Bacteria as tumor therapeutics?

Authors:  Tobias A Oelschlaeger
Journal:  Bioeng Bugs       Date:  2010-01-15

5.  From spinach scare to cancer care.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

6.  Persistent enhancement of bacterial motility increases tumor penetration.

Authors:  Dana N Thornlow; Emily L Brackett; Jonathan M Gigas; Nele Van Dessel; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2015-09-04       Impact factor: 4.530

7.  Single-cell analysis demonstrates how nutrient deprivation creates apoptotic and quiescent cell populations in tumor cylindroids.

Authors:  Byoung-Jin Kim; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2008-11-01       Impact factor: 4.530

8.  Tuning payload delivery in tumour cylindroids using gold nanoparticles.

Authors:  Byoungjin Kim; Gang Han; Bhushan J Toley; Chae-Kyu Kim; Vincent M Rotello; Neil S Forbes
Journal:  Nat Nanotechnol       Date:  2010-04-11       Impact factor: 39.213

9.  Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression.

Authors:  Katharina Galmbacher; Martin Heisig; Christian Hotz; Joerg Wischhusen; Antoine Galmiche; Birgit Bergmann; Ivaylo Gentschev; Werner Goebel; Ulf R Rapp; Joachim Fensterle
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

10.  Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice.

Authors:  S Ganai; R B Arenas; N S Forbes
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.